Results
Revise Search
-
Filters:
- All Records
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Health human resources
- 1987
Prelicensure clinical training programs
https://policybase.cma.ca/en/permalink/policy565
- Last Reviewed
- 2017-03-04
- Date
- 1987-08-25
- Topics
- Health human resources
- Resolution
- GC87-67
- That provision should be made for enough flexibility within prelicensure clinical training programs to prepare physicians for a variety of practice situations in Canada (eg. rural, isolated, urban) without undue prolongation of the training period.
- Policy Type
- Policy resolution
- Last Reviewed
- 2017-03-04
- Date
- 1987-08-25
- Topics
- Health human resources
- Resolution
- GC87-67
- That provision should be made for enough flexibility within prelicensure clinical training programs to prepare physicians for a variety of practice situations in Canada (eg. rural, isolated, urban) without undue prolongation of the training period.
- Text
- That provision should be made for enough flexibility within prelicensure clinical training programs to prepare physicians for a variety of practice situations in Canada (eg. rural, isolated, urban) without undue prolongation of the training period.
Specialty training for family medicine residents
https://policybase.cma.ca/en/permalink/policy572
- Last Reviewed
- 2017-03-04
- Date
- 1987-08-25
- Topics
- Health human resources
- Resolution
- GC87-66
- That appropriate training in speciality areas of medicine be provided to family medicine residents within the existing two years of the residency training program where possible.
- Policy Type
- Policy resolution
- Last Reviewed
- 2017-03-04
- Date
- 1987-08-25
- Topics
- Health human resources
- Resolution
- GC87-66
- That appropriate training in speciality areas of medicine be provided to family medicine residents within the existing two years of the residency training program where possible.
- Text
- That appropriate training in speciality areas of medicine be provided to family medicine residents within the existing two years of the residency training program where possible.
Adverse reactions between alcohol and drug products
https://policybase.cma.ca/en/permalink/policy805
- Last Reviewed
- 2017-03-04
- Date
- 1987-08-25
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC87-31
- That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
- Policy Type
- Policy resolution
- Last Reviewed
- 2017-03-04
- Date
- 1987-08-25
- Resolution
- GC87-31
- That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
- Text
- That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
Drug product substitution
https://policybase.cma.ca/en/permalink/policy806
- Last Reviewed
- 2017-03-04
- Date
- 1987-08-25
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC87-39
- The Canadian Medical Association supports the position that: 1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and 2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
- Policy Type
- Policy resolution
- Last Reviewed
- 2017-03-04
- Date
- 1987-08-25
- Resolution
- GC87-39
- The Canadian Medical Association supports the position that: 1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and 2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
- Text
- The Canadian Medical Association supports the position that: 1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and 2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.